| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |